From the Guidelines
To rule out pulmonary embolism (PE), a CT pulmonary angiogram (CTPA) is the preferred imaging study. This recommendation is based on the evidence from the American College of Physicians [ 1 ], which suggests that CTPA is the most appropriate imaging test for patients with a high pretest probability of PE. The use of CTPA has been shown to have a high sensitivity and specificity for detecting PE, and it is able to identify alternative diagnoses that may explain the patient's symptoms [ 1 ].
Key Points to Consider
- CTPA uses intravenous contrast material to visualize the pulmonary arteries and detect filling defects caused by blood clots.
- The procedure typically takes about 15-30 minutes to complete, with the actual scanning time being only a few minutes.
- Patients will need to have an IV placed for contrast administration and may be asked to hold their breath briefly during the scan.
- CTPA has largely replaced ventilation-perfusion (V/Q) scans as the first-line imaging test for suspected PE due to its higher sensitivity and specificity.
- Patients with impaired kidney function may require special consideration regarding contrast use, and those with severe contrast allergies may need pre-medication or alternative imaging approaches.
Clinical Considerations
- The clinical probability of PE should be assessed using validated clinical prediction rules, such as the Wells rule or the Geneva rule [ 1 ].
- Patients with a low or intermediate pretest probability of PE may undergo a high-sensitivity d-dimer measurement as the initial diagnostic test [ 1 ].
- The use of age-adjusted d-dimer thresholds may be considered in patients older than 50 years [ 1 ].
Recent Guidelines
- The American College of Radiology Appropriateness Criteria recommend CTPA as the preferred imaging study for suspected PE [ 1 ].
- The European Society of Cardiology guidelines also recommend CTPA as the first-line imaging test for suspected PE [ 1 ].
From the Research
Computed Tomography for Pulmonary Embolism
- Computed Tomography Pulmonary Angiography (CTPA) is the imaging test of first choice to rule out Pulmonary Embolism (PE) 2, 3, 4.
- CTPA has been shown to have a high sensitivity and specificity for the diagnosis of pulmonary embolism 2, 3, 5.
- The presence or absence of pulmonary embolism can be determined with sufficient certainty without the need for additional imaging tests after a negative CTPA 2, 3, 5.
Alternative Imaging Modalities
- Ventilation-perfusion scintigraphy is reserved for patients with a stringent contraindication for CTPA 2.
- Compression ultrasonography is reserved for patients with concomitant symptomatic deep vein thrombosis 2.
- Magnetic Resonance Pulmonary Angiography is not a suitable alternative for CTPA 2.
- Single Photon Emission Tomography (SPECT) V/Q scanning offers a nuclear medicine modality that is an alternative to CTPA in at least some patients with suspected pulmonary embolism at a fraction of the risk of radiation exposure 3.
Diagnostic Algorithms
- Diagnostic algorithms using CTPA or V/Q scanning have proven to be comparably safe to exclude the diagnosis of pulmonary embolism 3, 5.
- Excluding low-risk patients for pulmonary embolism as defined by clinical scoring systems and D-dimer testing would enhance the yield of diagnostic testing 3, 5.
- CTPA is the most reliable test for diagnosis of pulmonary embolism, but diagnostic algorithms using V/Q scanning may be preferred in some patient populations 3.